FDA Approves Zevtera for Serious Bacterial Infections.

DIARRHEA; BLOODBORNE infections; CATHETER-related infections; HEADACHE; UNITED States. Food & Drug Administration; STAPHYLOCOCCUS aureus; ENDOCARDITIS; COMMUNITY-acquired pneumonia; DISEASES; CEPHALOSPORINS; BACTERIAL diseases; LINEZOLID; NAUSEA; CEFTRIAXONE

The article focuses on the Food and Drug Administration's (FDA) approval of Basilea's Zevtera (ceftobiprole medocaril sodium) for different infections such as Staphylococcus aureus bloodstream infections, acute bacterial skin and skin structure infections, and community-acquired bacterial pneumonia. Topics include the expected coverage and pricing of Zevtera under the diagnosis-related group (DRG) bundled payment system.